SCHEMBL10193018

SCHEMBL10193018

CS/C(N)=N\Cc1cccc(NC(C)=O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.52
ALDH1A1 P00352 5/20 0.48
NPSR1 Q6W5P4 1/20 0.47
PKM P14618 1/20 0.46
RAB9A P51151 2/20 0.46
POLB P06746 1/20 0.46
NR4A1 P22736 1/20 0.46
HSD17B10 Q99714 2/20 0.45
CYP1A2 P05177 1/20 0.45
MEN1 O00255 1/20 0.45
TSHR P16473 1/20 0.45
KMT2A Q03164 1/20 0.45
SIRT2 Q8IXJ6 1/20 0.45
SIRT3 Q9NTG7 1/20 0.45
NOS3 P29474 1/20 0.44
NOS1 P29475 1/20 0.44
NOS2 P35228 1/20 0.44
NLRP3 Q96P20 1/20 0.44
NAPRT Q6XQN6 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10193223 0.80 NR3C1 (0.44) ALDH1A1POLBHSD17B10CYP1A2NOS3
SCHEMBL10193222 0.79 ALDH1A1 (0.51) ALDH1A1RAB9AHSD17B10MEN1TSHR
SCHEMBL10193927 0.76 BACE1 (0.49) RAB9ASIRT2SIRT3SMN1; SMN2
SCHEMBL9062832 0.75 NOS1 (0.68) ALDH1A1RAB9ACYP1A2NOS3NOS1
SCHEMBL5037396 0.75 ALDH1A1 (0.57) AOC3ALDH1A1NPSR1RAB9APOLB
SCHEMBL2545099 0.75 ALDH1A1 (0.61) AOC3ALDH1A1NPSR1RAB9APOLB
SCHEMBL843452 0.73 AOC3 (0.55) AOC3ALDH1A1NPSR1RAB9APOLB
SCHEMBL875279 0.73 AOC3 (0.55) AOC3ALDH1A1NPSR1RAB9APOLB
Hydrochloric Acid SCHEMBL1127877 0.73 ALDH1A1 (0.59) AOC3ALDH1A1NPSR1RAB9APOLB
SCHEMBL11868133 0.73 ALDH1A1 (0.59) ALDH1A1RAB9APOLBNR4A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2415756-A1 ISOTHIOUREA DERIVATIVES OR ISOUREA DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY Shionogi&Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120015961-A1 ISOTHIOUREA DERIVATIVES OR ISOUREA DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY SHIONOGI & CO., LTD. (JP) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015961-A1 ISOTHIOUREA DERIVATIVES OR ISOUREA DERIVATIVES HAVING BACE1 INHIBITORY ACTIVITY BACE1, BACE2, APP AOC3 2765/4885ALDH1A1 1013/4885NPSR1 1963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.